X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (98) 98
humans (87) 87
oncology (85) 85
female (70) 70
cancer (45) 45
middle aged (41) 41
aged (39) 39
chemotherapy (31) 31
adult (28) 28
male (26) 26
radiotherapy (22) 22
prognosis (21) 21
survival (19) 19
clinical trials (17) 17
aged, 80 and over (16) 16
metastasis (16) 16
obstetrics & gynecology (16) 16
patients (16) 16
quality of life (15) 15
carcinoma (14) 14
research (14) 14
tumors (14) 14
care and treatment (13) 13
ovarian cancer (13) 13
prospective studies (13) 13
therapy (13) 13
antineoplastic agents - therapeutic use (12) 12
endometrial cancer (12) 12
lung cancer (12) 12
mutation (12) 12
oncology, experimental (12) 12
treatment outcome (12) 12
cancer patients (11) 11
cancer therapies (11) 11
cervical cancer (11) 11
medicine, general & internal (11) 11
women (11) 11
analysis (10) 10
australia (10) 10
hematology, oncology and palliative medicine (10) 10
neoplasm staging (10) 10
risk factors (10) 10
survival analysis (10) 10
antineoplastic combined chemotherapy protocols - therapeutic use (9) 9
diagnosis (9) 9
metastases (9) 9
multiple myeloma - drug therapy (9) 9
retrospective studies (9) 9
studies (9) 9
cisplatin (8) 8
disease-free survival (8) 8
hematology (8) 8
medical prognosis (8) 8
neoplasms (8) 8
ovarian neoplasms - drug therapy (8) 8
quality-of-life (8) 8
recurrence (8) 8
abridged index medicus (7) 7
carboplatin (7) 7
clinical-trials (7) 7
follow-up studies (7) 7
gynecologic-oncology-group (7) 7
radiation therapy (7) 7
radiology, nuclear medicine & medical imaging (7) 7
survival rate (7) 7
article (6) 6
breast cancer (6) 6
carboplatin - administration & dosage (6) 6
deoxyribonucleic acid--dna (6) 6
endometrial neoplasms - pathology (6) 6
health care sciences & services (6) 6
immunohistochemistry (6) 6
intervention (6) 6
lung cancer, non-small cell (6) 6
lung neoplasms - drug therapy (6) 6
medicine & public health (6) 6
toxicity (6) 6
trial (6) 6
uterine cervical neoplasms - pathology (6) 6
uterine cervical neoplasms - therapy (6) 6
cancer-patients (5) 5
care (5) 5
cervix (5) 5
combined modality therapy (5) 5
communication (5) 5
disease progression (5) 5
endometrial neoplasms - therapy (5) 5
health aspects (5) 5
immunotherapy (5) 5
life (5) 5
medical oncology (5) 5
mortality (5) 5
multiple myeloma (5) 5
nursing (5) 5
outcomes (5) 5
pain medicine (5) 5
palliative care (5) 5
palliative treatment (5) 5
pathology (5) 5
surveys and questionnaires (5) 5
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Thorax, ISSN 0040-6376, 08/2019, Volume 74, Issue 8, pp. 787 - 796
BackgroundLung cancer is associated with poor health-related quality of life (HRQoL) and high symptom burden. This trial aimed to assess the efficacy of... 
Intervention | Lung cancer | Melanoma | Clinical trials | Systematic review | Patients | Cancer therapies | Quality of life | Skin cancer | Studies | Physical fitness | Chemotherapy | Exercise | Medical prognosis | Chronic obstructive pulmonary disease | Rehabilitation
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2016, Volume 17, Issue 10, pp. 1386 - 1395
Journal Article
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2016, Volume 17, Issue 8, pp. 1114 - 1126
Summary Background About 15% of patients with endometrial cancer have high-risk features and are at increased risk of distant metastases and endometrial... 
Hematology, Oncology and Palliative Medicine | CARCINOMA PATIENTS | EXTERNAL-BEAM RADIOTHERAPY | GYNECOLOGIC-ONCOLOGY-GROUP | ONCOLOGY | PELVIC RADIATION-THERAPY | EUROPEAN-ORGANIZATION | STAGE-I | OVARIAN-CANCER | INTERMEDIATE-RISK | III TRIAL | CHEMOTHERAPY | Endometrial Neoplasms - radiotherapy | Prognosis | Follow-Up Studies | Humans | Middle Aged | Gastrointestinal Diseases - etiology | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Adenocarcinoma, Clear Cell - radiotherapy | Chemoradiotherapy, Adjuvant - adverse effects | Nervous System Diseases - diagnosis | Case-Control Studies | Gastrointestinal Diseases - diagnosis | Cisplatin - administration & dosage | Neoplasm Grading | Radiotherapy, Adjuvant - adverse effects | Cystadenocarcinoma, Serous - therapy | Female | Paclitaxel - administration & dosage | Cystadenocarcinoma, Serous - secondary | Neoplasm Invasiveness | Carboplatin - administration & dosage | Survival Rate | Lymphatic Metastasis | Hematologic Diseases - diagnosis | Adenocarcinoma, Clear Cell - secondary | Hematologic Diseases - etiology | Adenocarcinoma, Clear Cell - therapy | Endometrial Neoplasms - therapy | Nervous System Diseases - etiology | Quality of Life | Endometrial Neoplasms - pathology | Aged | Neoplasm Staging | Cystadenocarcinoma, Serous - radiotherapy | Endometrial cancer | Oncology, Experimental | Radiation | Metastasis | Research | Radiotherapy | Health aspects | Risk factors | Cancer | Index Medicus
Journal Article
by Patch, Ann-Marie and Christie, Elizabeth L and Etemadmoghadam, Dariush and Garsed, Dale W and George, Joshy and Fereday, Sian and Nones, Katia and Cowin, Prue and Alsop, Kathryn and Bailey, Peter J and Kassahn, Karin S and Newell, Felicity and Quinn, Michael C.J and Kazakoff, Stephen and Quek, Kelly and Wilhelm-Benartzi, Charlotte and Curry, Ed and Leong, Huei San and Hamilton, Anne and Mileshkin, Linda and Au-Yeung, George and Kennedy, Catherine and Hung, Jillian and Chiew, Yoke-Eng and Harnett, Paul and Friedlander, Michael and Quinn, Michael and Pyman, Jan and Cordner, Stephen and O'Brien, Patricia and Leditschke, Jodie and Young, Greg and Strachan, Kate and Waring, Paul and Azar, Walid and Mitchell, Chris and Traficante, Nadia and Hendley, Joy and Thorne, Heather and Shackleton, Mark and Miller, David K and Arnau, Gisela Mir and Tothill, Richard W and Holloway, Timothy P and Semple, Timothy and Harliwong, Ivon and Nourse, Craig and Nourbakhsh, Ehsan and Manning, Suzanne and Idrisoglu, Senel and Bruxner, Timothy J. C and Christ, Angelika N and Poudel, Barsha and Holmes, Oliver and Anderson, Matthew and Leonard, Conrad and Lonie, Andrew and Hall, Nathan and Wood, Scott and Taylor, Darrin F and Xu, Qinying and Lynn Fink, J and Waddell, Nick and Drapkin, Ronny and Stronach, Euan and Gabra, Hani and Brown, Robert and Jewell, Andrea and Nagaraj, Shivashankar H and Markham, Emma and Wilson, Peter J and Ellul, Jason and McNally, Orla and Doyle, Maria A and Vedururu, Ravikiran and Stewart, Collin and Lengyel, Ernst and Pearson, John V and Waddell, Nicola and Defazio, Anna and Grimmond, Sean M and Bowtell, David D. L and Australian Ovarian Canc Study Grp and Australian Ovarian Cancer Study Group and The Australian Ovarian Cancer Study Group
Nature, ISSN 0028-0836, 05/2015, Volume 521, Issue 7553, pp. 489 - 494
Journal Article
by Pujade-Lauraine, Eric and Ledermann, Jonathan and Ledermann, Jonathan A and Selle, Frédéric and Gebski, Val and Penson, Richard and Penson, Richard T and Oza, Amit M and Oza, Amit and Korach, Jacob and Huzarski, Tomasz and Poveda, Andrés and Pignata, Sandro and Friedlander, Michael and Colombo, Nicoletta and Harter, Philipp and Fujiwara, Keiichi and Ray-Coquard, Isabelle and Banerjee, Susana and Liu, Joyce and Lowe, Elizabeth S and Bloomfield, Ralph and Pautier, Patricia and Byrski, Tomasz and Scambia, Giovanni and Nicoletto, Maria and Nussey, Fiona and Clamp, Andrew and Poveda Velasco, Andrés and Rodrigues, Manuel and Lotz, Jean-Pierre and Provencher, Diane and Prat Aparicio, Aleix and Vidal Boixader, Laura and Scott, Clare and Tamura, Kenji and Yunokawa, Mayu and Lisyanskaya, Alla and Medioni, Jacques and Pécuchet, Nicolas and Dubot, Coraline and de la Motte Rouge, Thibault and Kaminsky, Marie-Christine and Weber, Béatrice and Lortholary, Alain and Parkinson, Christine and Williams, Sarah and Cosin, Jonathan and Hoffman, James and Plante, Marie and Covens, Allan and Sonke, Gabe and Joly, Florence and Floquet, Anne and Hirte, Holger and Amit, Amnon and Park-Simon, Tjoung-Won and Matsumoto, Koji and Tjulandin, Sergei and Kim, Jae Hoon and Kim, Byoung-Gie and Kim, Jae Weon and Gladieff, Laurence and Sabbatini, Roberto and O'Malley, David and Timmins, Patrick and Kredentser, Daniel and Laínez Milagro, Nuria and Barretina Ginesta, Maria Pilar and Tibau Martorell, Ariadna and Gómez de Liaño Lista, Alfonso and Ojeda González, Belén and Mileshkin, Linda and Mandai, Masaki and Boere, Ingrid and Ottevanger, Petronella and Nam, Joo-Hyun and Filho, Elias and Hamizi, Salima and Cognetti, Francesco and Warshal, David and Dickson-Michelson, Elizabeth and Kamelle, Scott and McKenzie, Nathalie and Rodriguez, Gustavo and Armstrong, Deborah and Chalas, Eva and Celano, Paul and Behbakht, Kian and Davidson, Susan and Welch, Stephen and Helpman, Limor and Fishman, Ami and Bruchim, Ilan and Sikorska, Magdalena and Słowińska, Anna and Rogowski, Wojciech and Bidziński, Mariusz and Śpiewankiewicz, Beata and Casado Herraez, Antonio and ... and SOLO2-ENGOT-Ov21 Investigators and SOLO2/ENGOT-Ov21 investigators
The Lancet Oncology, ISSN 1470-2045, 09/2017, Volume 18, Issue 9, pp. 1274 - 1284
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 05/2012, Volume 30, Issue 13, pp. 1527 - 1533
Purpose PF-00562271 is a novel inhibitor of focal adhesion kinase (FAK). The objectives of this study were to identify the recommended phase II dose (RP2D) and... 
FAK OVEREXPRESSION | INVASIVENESS | MIGRATION | CELLS | HEPATOCELLULAR-CARCINOMA | METASTASIS | ONCOLOGY | PYK2 | PHOSPHORYLATION | CANCER | PROGRESSION | United States | Humans | Middle Aged | Male | Positron-Emission Tomography | Antineoplastic Agents - administration & dosage | Protein Kinase Inhibitors - adverse effects | Molecular Targeted Therapy | Focal Adhesion Kinase 2 - antagonists & inhibitors | Dose-Response Relationship, Drug | Enzyme Inhibitors - administration & dosage | Enzyme Inhibitors - pharmacokinetics | Focal Adhesion Kinase 2 - metabolism | Antineoplastic Agents - adverse effects | Aged, 80 and over | Adult | Female | Antineoplastic Agents - pharmacokinetics | Radiopharmaceuticals | Focal Adhesion Kinase 1 - metabolism | Protein Kinase Inhibitors - pharmacokinetics | Drug Administration Schedule | Pyrimidines - administration & dosage | Neoplasms - enzymology | Treatment Outcome | Neoplasms - diagnostic imaging | Sulfonamides - pharmacokinetics | Neoplasms - drug therapy | Canada | Protein Kinase Inhibitors - administration & dosage | Maximum Tolerated Dose | Cytochrome P-450 CYP3A Inhibitors | Cytochrome P-450 CYP3A - metabolism | Pyrimidines - adverse effects | Midazolam - metabolism | Pyrimidines - pharmacokinetics | Sulfonamides - adverse effects | Fluorodeoxyglucose F18 | Aged | Australia | Neoplasm Staging | Neoplasms - pathology | Nonlinear Dynamics | Focal Adhesion Kinase 1 - antagonists & inhibitors | Sulfonamides - administration & dosage | Index Medicus
Journal Article
by de Boer, Stephanie M and Powell, Melanie E and Mileshkin, Linda and Katsaros, Dionyssios and Bessette, Paul and Haie-Meder, Christine and Ottevanger, Petronella B and Ledermann, Jonathan A and Khaw, Pearly and Colombo, Alessandro and Fyles, Anthony and Baron, Marie-Helene and Jürgenliemk-Schulz, Ina M and Kitchener, Henry C and Nijman, Hans W and Wilson, Godfrey and Brooks, Susan and Carinelli, Silvestro and Provencher, Diane and Hanzen, Chantal and Lutgens, Ludy C H W and Smit, Vincent T H B M and Singh, Naveena and Do, Viet and D'Amico, Romerai and Nout, Remi A and Feeney, Amanda and Verhoeven-Adema, Karen W and Putter, Hein and Creutzberg, Carien L and McCormack, Mary and Whitmarsh, Karen and Allerton, Rozenn and Gregory, Deborah and Symonds, Paul and Hoskin, Peter J and Adusumalli, Madhavi and Anand, Anjana and Wade, Robert and Stewart, Alexandra and Taylor, Wendy and Kruitwagen, Roy F.P.M and Hollema, Harry and Pras, Elizabeth and Snyers, An and Stalpers, Lukas and Jobsen, Jan J and Slot, Annerie and Mens, Jan-Willem M and Stam, Tanja C and Van Triest, Baukelien and Van der Steen - Banasik, Elzbieta M and De Winter, Karin A.J and Quinn, Michael A and Kolodziej, Ilka and Pyman, Jan and Johnson, Carol and Capp, Anne and Fossati, Roldano and Gribaudo, Sergio and Lissoni, Andrea A and Ferrero, Annamaria and Artioli, Grazia and Davidson, Cathy and McLachlin, C. Meg and Ghatage, Prafull and Rittenberg, Paula V.C and Souhami, Luis and Thomas, Gillian and Duvillard, Pierre and Berton-Rigaud, Dominique and Tubiana-Mathieu, Nicole and PORTEC Study Grp and PORTEC study group
The Lancet Oncology, ISSN 1470-2045, 03/2018, Volume 19, Issue 3, pp. 295 - 309
Journal Article